Erik Muser

Early Assessment of Ustekinumab for Crohn’s Disease: A Chart Review

BACKGROUND: Ustekinumab was approved by the FDA in September 2016 for the treatment of patients with moderate-to-severe Crohn’s Disease (CD). Little is published about either the health a...

Antuane Allen ;

Jennifer Clerie , BS ;

Charles Ruetsch , PhD;

Tigwa Davis , PhD;

Erik Muser ;

James Izanec ;

Camilo Obando ;

11/20/2018

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Erik Muser

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products